Feline Immunodeficiency Virus
- Lentivirus.
- Five subtypes-> A in the UK.
- Most common in older males, outside cats or sick cats.
Pathogenesis:
- Bite wound.
- Replication in leucocytes.
- Tissue localisation e.g. CNS.
- 6-8 weeks. Lymphadenopathy, neutropenia and decreased CD4:CD8 ratio.
- Prolonged asymptomatic period.
- Immunosuppression.
Clinical signs-> Immunosuppression resulting in secondary bacterial infections. Direct virus effects e.g. CNS disease. May also result in tumours.
Epidemiology:
- Persistant infective antibody positive.
- Uninfected antibody positive.
- Test-> 90% sensitivity and 98% specificity, not used well for positive tests at low prevalence hence in house tests should be repeated by an independent test.
Diagnosis:
- PCR- problems as not all strains recognised and problems with sensitivity.
- Diagnosis- viral isolate.
- Antibody e.g. western blotting.
- All kittens may be virus positive and retest as there is the MDA to consider.
Transmission:
- Virus in saliva- bites/fights.
- Transplacental.
- Birth- milk.
- Does not survive well in the environment.
Prevention and control:
- Isolate infected cats.
- Vaccine-> killed vaccine with 2 FIV strains/adjuv vaccine.
- Prevent cats fighting.
Feline Leukaemia Virus
- RNA genome with P27 protein core. Envelope and GP70 spikes. Only group A transmitted.
Clinical Signs:
- Neoplastic disease of myeloid and lymphoid. Results in lymphomas- mediastinal (90% FeLV positive), multicentric, ailmentary and extranodal e.g. spinal/renal.
- Leukaemia-> erythroleukaemia, and reticuloendotheliosis.
- Anaemia, immunosuppression, infertility and neurological disease.
Transmission:
- Inactivated in the environment.
- Congenital infection.
- Oronasal- virus shed in saliva.
- Prolonged intimate contact e.g. grooming.
Pathogenesis:
- Transient viraemia- neutralising antibody limits the spread of infection. Up to 8 weeks and infection may spread to bone marrow. Normally mounts effective immunity.
- Latent infection- bone marrow, short lived. Blood tests are FeLV negative.
- Persistent viraemia- grave prognosis. Ineffective immunity mounted. Replicates in bone marrow cells. Virus and P27 ag in bood. <16 week old cats, high viral dose, previous infection, vaccination or maternal antibodies.
Epidemiology:
- Age related resistant to development of persistent viraemia.
- 2-4 years old generally.
- Multicat houshold with prolonged contact. Endemic infection= 30% cats persistent viraemic.
Diagnosis:
- Non specific tests e.g. anaemia.
- Detect virus/viral antigen P27- ELISA, rapid immunomigratory assay, immunoflourescence.
- Viral plasma isolate.
- Detect FeLV neutralising antibody- detects immune cats.
Control:
- Pets- vaccinated and not high risk.
- Breeding- vaccination not 100%. Regular test and remove and remove any new cats.
- In house tests, possible false positives, so retest all confirm +ve with a second test and retest any positives on the second test. Tested by viral isolation/IF.
Vaccination:
- Problems= adverse reactions and lack of efficacy.
- Test before vaccination- high risk cats.
- Protects against persistent infection. 12 months. Not 100%. A, B and C types. Canarypox vector.
- Inactive/virus particles with recombinant gp70 adjuvinated.
No comments:
Post a Comment